Literature DB >> 10702603

Phytoestrogens and prostate disease.

H Adlercreutz1, W Mazur, P Bartels, V Elomaa, S Watanabe, K Wähälä, M Landström, E Lundin, A Bergh, J E Damber, P Aman, A Widmark, A Johansson, J X Zhang, G Hallmans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10702603     DOI： 10.1093/jn/130.3.658S

Source DB:  PubMed          Journal:  J Nutr        ISSN： 0022-3166            Impact factor:   4.798


× No keyword cloud information.
  17 in total

1.  Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.

Authors:  Li-Hua Chen; Jing Fang; Zhijian Sun; Huaixing Li; Ying Wu; Wendy Demark-Wahnefried; Xu Lin
Journal:  J Nutr       Date:  2009-02-11       Impact factor: 4.798

2.  Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy.

Authors:  Mohammad R Noori-Daloii; Majid Momeny; Mehdi Yousefi; Forough Golsaz Shirazi; Mehdi Yaseri; Nasrin Motamed; Nazanin Kazemialiakbar; Saeed Hashemi
Journal:  Med Oncol       Date:  2010-07-02       Impact factor: 3.064

3.  Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.

Authors:  Nagi B Kumar; Karen Besterman-Dahan; Loveleen Kang; Julio Pow-Sang; Ping Xu; Kathy Allen; Diane Riccardi; Jeffrey P Krischer
Journal:  Clin Med Urol       Date:  2008-04-16

4.  Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.

Authors:  John V Heymach; Terry J Shackleford; Hai T Tran; Suk-Young Yoo; Kim-Anh Do; Melanie Wergin; Pierre Saintigny; Robin T Vollmer; Thomas J Polascik; Denise C Snyder; Mack T Ruffin; Shaoyu Yan; Mark Dewhirst; Ajaikumar B Kunnumakkara; Bharat B Aggarwal; Wendy Demark-Wahnefried
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-15

5.  Ameliorative effects of Monascus pilosus-fermented black soybean (Glycine max L. Merrill) on high-fat diet-induced obesity.

Authors:  Hong-Geun Oh; Young-Rye Kang; Hak-Yong Lee; Jung-Hoon Kim; Eun-Hye Shin; Bong-Gun Lee; Sang-Hoon Park; Dae-In Moon; Ok-Jin Kim; In-Ae Lee; Jongkeun Choi; Ji-Ean Lee; Kwang-Hyun Park; Joo-Won Suh
Journal:  J Med Food       Date:  2014-08-12       Impact factor: 2.786

6.  Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.

Authors:  Nagi B Kumar; Loveleen Kang; Julio Pow-Sang; Ping Xu; Kathy Allen; Diane Riccardi; Karen Besterman-Dahan; Jeffrey P Krischer
Journal:  J Soc Integr Oncol       Date:  2010

Review 7.  Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.

Authors:  C R Sirtori
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 8.  Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

Authors:  Melanie J Grubisha; Donald B DeFranco
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

9.  A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.

Authors:  Nagi B Kumar; Jeffrey P Krischer; Kathy Allen; Diane Riccardi; Karen Besterman-Dahan; Raoul Salup; Lovellen Kang; Ping Xu; Julio Pow-Sang
Journal:  Nutr Cancer       Date:  2007       Impact factor: 2.900

10.  Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats.

Authors:  Jessica R Tolman; Edwin D Lephart; Kenneth Dr Setchell; Dennis L Eggett; Merrill J Christensen
Journal:  Nutr Metab (Lond)       Date:  2008-11-10       Impact factor: 4.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.